Sk. Gandhi et al., ATRIAL-FLUTTER - A NEWLY RECOGNIZED COMPLICATION OF PEDIATRIC LUNG TRANSPLANTATION, Journal of thoracic and cardiovascular surgery, 112(4), 1996, pp. 984-991
Background and methods: Atrial Butter after pediatric lung transplanta
tion has not previously been reported. We reviewed the records of 78 c
hildren who underwent lung transplantation at our institution to chara
cterize the incidence and clinical course of postoperative atrial Butt
er, The diagnosis was based on either a surface or transesophageal ele
ctrocardiogram that demonstrated a fixed cycle length atrial tachycard
ia that did not require ventricular participation. Results: Atrial flu
tter occurred in seven of 62 (11.3%) patients who underwent bilateral
sequential lung transplantation, zero of 10 patients after single lung
transplantation. and zero of six patients after heart-lung transplant
ation. Ages of the patients with atrial Butter ranged from 2.5 months
to 14 years. Electrocardiographic findings among patients varied with
respect to p-wave morphology and atrioventricular conduction. No patie
nt had a prior atrial arrhythmia or coexisting structural cardiac dise
ase. None had atrial flutter in relation to a rejection episode. Two p
atients had atrial flutter transiently during the first postoperative
day, hut it resolved spontaneously. Five patients had recurrent atrial
flutter that began 13 +/- 7 days after the operation. The mean cycle
length of atrial Butter was 196 +/- 65 msec The arrhythmia was unrespo
nsive to digoxin in four patients to whom it was administered, It was
controlled with procainamide in four patients and with flecainide in o
ne. At 1 and 6 months after lung transplantation, procainamide was dis
continued in two patients without recurrence One patient died of bronc
hiolitis obliterans 6 months after the operation while stilt receiving
flecainide Two patients continue to receive procainamide 4 and 7 mont
hs after transplantation, Conclusion: (1) Atrial flutter commonly occu
rs after bilateral lung transplantation in children, (2) Electrocardio
graphic manifestations are variable, (3) Type 1 antiarrhythmic agents
provide satisfactory control.